Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 AUD | -0.82% | -0.41% | -15.92% |
Mar. 05 | Australia shares inch lower as miners weigh; GDP data in focus | RE |
Feb. 28 | Australian Clinical Labs Falls 11% After Trimming Interim Dividend on Lower H1 FY24 EPS | MT |
Sales 2024 * | 683M 446M | Sales 2025 * | 711M 464M | Capitalization | 491M 321M |
---|---|---|---|---|---|
Net income 2024 * | 29M 18.93M | Net income 2025 * | 38M 24.8M | EV / Sales 2024 * | 0.78 x |
Net Debt 2024 * | 39.25M 25.62M | Net Debt 2025 * | 17.81M 11.63M | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
17.2
x | P/E ratio 2025 * |
12.7
x | Employees | 5,115 |
Yield 2024 * |
3.51% | Yield 2025 * |
4.63% | Free-Float | 55.78% |
Latest transcript on Australian Clinical Labs Limited
1 day | -0.82% | ||
1 week | -0.41% | ||
Current month | -9.67% | ||
1 month | -9.67% | ||
3 months | -20.07% | ||
6 months | -8.30% | ||
Current year | -15.92% |
Managers | Title | Age | Since |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
James Davison
DFI | Director of Finance/CFO | - | 14-12-31 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 14-12-31 |
Leanne Rowe
BRD | Director/Board Member | 67 | 21-04-27 |
Director/Board Member | - | 23-08-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 2.43 | -0.82% | 94 036 |
24-04-29 | 2.45 | -0.41% | 144,588 |
24-04-26 | 2.46 | -1.20% | 246,118 |
24-04-24 | 2.49 | +2.05% | 198,250 |
24-04-23 | 2.44 | +1.24% | 258,572 |
Delayed Quote Australian S.E., April 30, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.92% | 322M | |
-14.58% | 85.02B | |
+15.05% | 82.37B | |
+10.49% | 29.29B | |
-10.17% | 17.21B | |
-1.00% | 16.7B | |
-31.40% | 11.8B | |
+1.84% | 12.15B | |
+31.86% | 12.12B | |
-1.42% | 12.13B |
- Stock Market
- Equities
- ACL Stock